News
Dean
Introduction
Organization
Faculty
Research Highlights
Admission
Research Day
Location
Activity Features
National Taiwan University    |     NTU, College of Medicine
NTU, Department of Pharmacy
Graduate Institute of Clinical Pharmacy
Drug Research Center    |     Ching Kang Foundation
Center for Innovative Therapeutics Discovery
NTUH,Department of Pharmacy
Taiwan Society of Health-System Pharmacists
Alumni    |     Alumni in North America    |     AASP    |    
Instrumentation Booking System    |     Platform for Research and Inspiration in Regulatory Science
© copyright 2014 SP, NTU. All Rights Reserved.
No.33, Linsen S. Rd., Zhongzheng Dist., Taipei City 100025, Taiwan (R.O.C.)
TEL : (02)3366-8750~4    FAX : (02)2391-9098
Web person in charge: Tang-Yih Hsu
Contact Phone : (02)33668743
Latest Update : 2024 / 10 / 24
Privacy & Security Policy
Platform for Research and Inspiration in Regulatory Science
About UsResearchPublicationsNewsActivitiesContact
About Us
Wendy Huang Chern (黃文英)
Current position
  • Chairman / General Manager, AnnJi Pharmaceutical Co. Ltd, Taiwan (2019-)
Academic degree
  • Doctor of Philosophy in Toxicology, College of Science, North Carolina State University, USA (1993)
  • Bachelor of Science in Pharmacy, School of Pharmacy, College of Medicine, National Taiwan University, Taiwan (1978)
Experience
  • General Manager / Chief Executive Officer, Lumosa Therapeutics Co., Taiwan (2013-2019)
  • Vice President, GlaxoSmithKline, USA (2010-2013)
  • Senior Vice President, Stiefel Laboratories, USA (2007-2009)
  • Vice President, Connetics Corporation, USA (2004-2006)
  • Head, Early Compound Assessment and Safety Evaluation, Dermatology Research & Development Department, Aventis, USA (2003-2004)
  • Department Manager/Director, Dermatology Product Development Department, Dermik Laboratories (1998-2003)
  • Project Leader, Project Management and Regulatory Strategy, Dermik Laboratories (1997-1998)
  • Senior Scientist/Researcher Fellow, Rhône-Poulenc Rorer Pharmaceutical Inc., USA (1993-1997)
Research subjects
  • New drug development
  • Global drug registration
  • Business development